Trenary C Russell Iii - Net Worth and Insider Trading
Trenary C Russell Iii Net Worth
The estimated net worth of Trenary C Russell Iii is at least $18,645 dollars as of 2024-06-08. Trenary C Russell Iii is the CEO and President of Outlook Therapeutics Inc and owns about 2,746 shares of Outlook Therapeutics Inc (OTLK) stock worth over $18,645. Details can be seen in Trenary C Russell Iii's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Trenary C Russell Iii has not made any transactions after 2022-06-21 and currently still holds the listed stock(s).
Transaction Summary of Trenary C Russell Iii
Trenary C Russell Iii Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Trenary C Russell Iii owns 1 companies in total, including Outlook Therapeutics Inc (OTLK) .
Click here to see the complete history of Trenary C Russell Iii’s form 4 insider trades.
Insider Ownership Summary of Trenary C Russell Iii
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2022-06-21 | director & CEO and President |
Trenary C Russell Iii Latest Holdings Summary
Trenary C Russell Iii currently owns a total of 1 stock. Trenary C Russell Iii owns 2,746 shares of Outlook Therapeutics Inc (OTLK) as of June 21, 2022, with a value of $18,645.
Latest Holdings of Trenary C Russell Iii
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2022-06-21 | 2,746 | 6.79 | 18,645 |
Holding Weightings of Trenary C Russell Iii
Trenary C Russell Iii Form 4 Trading Tracker
According to the SEC Form 4 filings, Trenary C Russell Iii has made a total of 3 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Outlook Therapeutics Inc is the acquisition of 996 shares on June 21, 2022, which cost Trenary C Russell Iii around $21,121.
Insider Trading History of Trenary C Russell Iii
- 1
Trenary C Russell Iii Trading Performance
GuruFocus tracks the stock performance after each of Trenary C Russell Iii's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Trenary C Russell Iii is 21.57%. GuruFocus also compares Trenary C Russell Iii's trading performance to market benchmark return within the same time period. The performance of stocks bought by Trenary C Russell Iii within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Trenary C Russell Iii's insider trading performs compared to the benchmark.
Performance of Trenary C Russell Iii
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.5 | | | | | |
| Relative Return to S&P 500(%) | -1.71 | | | | | |
Trenary C Russell Iii Ownership Network
Trenary C Russell Iii Owned Company Details
What does Outlook Therapeutics Inc do?
Who are the key executives at Outlook Therapeutics Inc?
Trenary C Russell Iii is the director & CEO and President of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include Chief Commercial Officer Jeff Evanson , Chief Operating Officer Terry Dagnon , and director & 10 percent owner Ghiath M. Sukhtian .
Outlook Therapeutics Inc (OTLK) Insider Trades Summary
Over the past 18 months, Trenary C Russell Iii made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net sale of 368,671 shares made by Jeff Evanson , a net sale of 520,000 shares made by Terry Dagnon , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .
In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 1,882 shares, with a net purchase of 1,882 shares. During the past 18 months, 47,558 shares of Outlook Therapeutics Inc (OTLK) were sold and 5,006 shares were bought by its insiders, resulting in a net sale of 42,552 shares.
Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Outlook Therapeutics Inc Insider Transactions
Trenary C Russell Iii Mailing Address
Above is the net worth, insider trading, and ownership report for Trenary C Russell Iii. You might contact Trenary C Russell Iii via mailing address: 1700 E St Andrew Place, Santa Ana Ca 92705.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
